Of course, as an enterprise that has been deeply involved in the peptide industry, Sinopharm Peptide Valley is quite authoritative in the research of ginseng peptides. With the ability of innovation and breakthrough in academic research and production technology, it has won many national invention patents. According to the latest information from official website of Sinopharm Peptide Valley, on September 12, the patent of "a device for preparing American ginseng peptide" declared by Sinopharm Peptide Valley was authorized by China National Intellectual Property Administration again and obtained the invention patent certificate (patent number: ZL 2023 1 0 132354.0). The patent can realize the integration of chopping, enzymolysis and filtration processing, and the chopping, enzymolysis and filtration processes are all carried out in a closed container, which not only effectively improves the efficiency of preparation and processing of American ginseng peptide, but also effectively avoids the pollution problem caused by operation and improper operation during the processing of American ginseng peptide, and greatly improves the safety of product production.

It is worth mentioning that this patent is the fifth national invention patent obtained by Sinopharm Peptide Valley in 2023. Up to now, the total number of patents obtained by Sinopharm Peptide Valley has reached 10.

The scientific research strength of Sinopharm Peptide Valley in the field of ginseng peptide is not only at the leading level in China, but also successfully ranks among the research frontiers of the world peptide industry, pushing the academic research of small molecular peptides, research and development of ginseng peptide products and production technology to a new stage. Paying attention to academic research and upgrading iteration of production technology is an important source for Sinopharm Peptide Valley to maintain its core competitiveness as a high-tech enterprise, and it is also the reason why Sinopharm Peptide Valley can continuously promote the high-quality transformation and upgrading of the big health industry.